No retraction, correction or concern found when last checked on Oct 22, 2026.
Flavonoids as Natural Anti-Inflammatory Agents Targeting Nuclear Factor-Kappa B (NFκB) Signaling in Cardiovascular Diseases: A Mini Review
Ker Woon Choy, Dharmani Murugan, Xin-Fang Leong and 3 more
Frontiers in Pharmacology · 2019 · Review · CC BY
Abstract
Cardiovascular diseases (CVDs) such as angina, hypertension, myocardial ischaemia and heart failure are the leading causes of morbidity and mortality worldwide. One of the major transcription factors widely associated with CVDs is nuclear factor-kappa B (NFκB). NFκB activation initiate the canonical and non-conical pathways that promotes activation of transcription factors leading to inflammation, such as leukocyte adhesion molecules, cytokines, and chemokines. Flavonoids are bioactive polyphenolic compounds found abundantly in various fruits, vegetables, beverages (tea, coffee), nuts and cereal products with cardiovascular protective properties. Flavonoids can be classified into six subgroups based on their chemical structures: flavanones, flavones, flavonols, flavan-3-ols, isoflavones and anthocyanidins. As NFκB inhibitors, these flavonoids may modulate the expression of pro-inflammatory genes leading to the attenuation of the inflammatory responses underlying various cardiovascular pathology. This review presents an update on the anti-inflammatory actions of flavonoids via inhibition of NFκB mechanism supporting the therapeutic potential of these natural compounds in various CVDs.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Cardiovascular diseases (CVDs) represent the major burden of mortality and morbidity in the developed countries. The most common pathogeneses of CVDs are inflammatory processes. Various transcription factors are related to inflammatory responses in CVDs such as T-bet, signal transducer and activator of transcription 3 (STAT3), interferon regulatory factors (IRFs), activator protein 1 (AP-1), and transcription factor Bcl11b. However, the key player in the regulation of inflammation is the transcription factor nuclear factor kappa B (NFκB). The inhibition of NFκB pathway has been demonstrated to show beneficial effect in various CVDs including hypertension, myocardial infraction, and arteriosclerosis. These findings support that targeted inhibition of NFκB appears to be a promising strategy in reducing cardiovascular complications.
Flavonoids are plant polyphenolic compound derivatives from natural origin found in fruits, grains, vegetables, roots, bark, flowers, stems, tea, and wine. Non-plant natural products such as mushrooms and honey, plant extracts, plant juices, plant powders, and essential oils have shown to possess anti-inflammatory activities and many of these plant natural products have polyphenols as their major compound. However, the protective effects of flavonoid in CVDs via inhibition of NFκB are yet to be reviewed. Therefore, in this mini-review, we focused on the anti-inflammatory actions of flavonoids via inhibition of NFκB mechanism in CVDs.
Flavonoids and Its Subclass
Flavonoids are categorized into six subclasses depending on its chemical structures: flavones, flavonols, flavanones, isoflavones, flavan-3-ols, and anthocyanidins.
Flavones are found abundant in flowers, fruits, and leaves such as red peppers, celery, parsley, chamomile, mint, and ginkgo biloba. The most studied flavones are luteolin, apigenin, and tangeritin.
Flavonols such as kaempferol, myricetin, quercetin, rutin, fisetin, silymarin, and isorhamnetin are ubiquitous in foods such as saffron, onions, kale, lettuce, tomatoes, apples, grapes, berries, red wine, and tea.
Flavanones widely present in all citrus fruits, which gives the bitter taste of the juice and its peel. Oranges, lemons, and grapes are rich sources of flavanones and major compounds are hesperitin, naringenin, and eriodictyol.
Isoflavones are unique in that they resemble estrogen in structure and, therefore, are classified as phytoestrogens. There are found abundantly in soy products such as tofu, roasted soy nuts, and miso.
Flavan-3-ols, also called as dihydroflavonols, include catechin, epicatechin, gallocatechin, epigallocatechin, epicatechingallate, epigallocatechingallate, and procyanidin. The most commonly associated food with the flavan-3-ol compounds is black and green tea and fruits such as bananas, apples, blueberries, peaches, and pears.
Anthocyanins are rich in outer cell layers of fruits such as merlot grapes, raspberries, cranberries, red grapes, strawberries, blueberries, bilberries, and blackberries. The most commonly studied anthocyanins are cyanidin, delphinidin, malvidin, pelargonidin, and peonidin.
Nfκb Induced Inflammation and CVDs
There are a few cellular redox pathways involved in the development of the chronic inflammatory CVD, which includes NFκB. NFκB is a transcription factor that activates inhibitor of kappa B (IκB) kinase in the cytosol upon being stimulated by inflammatory stimuli. Subsequent signaling pathways via canonical or non-canonical lead to migration of NFκB toward the nucleus and hence initiates the targeting gene such as pro-inflammatory cells, monocytes, macrophages, and T and B cells ( Figure 1 ).
The canonical NFκB pathway responds rapidly to stimuli and activates NFκB, which increases pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha (TNF-α), which results in cell apoptosis. TNF-α receptor signaling plays an important role in the canonical pathway of NFκB in cell death via Jun N-terminal kinases (JNK), p38, and caspase 8 cascades. Furthermore, NFκB also activates angiotensin II, endothelin-1, and phenylephrine as hypertrophic agonist via IκB degradation and p65 nuclear translocation.
A central signaling component of the non-canonical NFκB pathway is NFκB-inducing kinase, which induces p100 phosphorylation through kinase IKKα in a slow manner. Ligands of a subset of tumor necrosis factor receptor (TNFR) superfamily members are typical inducers of the non-canonical NFκB pathway.
Quercetin
Quercetin or 3, 3′, 4′, 5, 7-pentahydroxyflvanone that falls into the category of flavonol is widely found in plants such as Ginkgo biloba, Hypericum perforatum, and Sambucus canadensis as well as vegetables such as apples, berries, grapes, onions, shallots, and tomatoes.
In a clinical study involving patients with chronic systemic inflammation (CSI) in stable coronary artery disease (CAD), quercetin showed anti-inflammatory effects with reduction in indicators of CSI. Quercetin decreased IL-1β and TNF-α levels in blood serum, in addition to decreasing the transcriptional activity of NFкB in blood mononuclear cells. In leptin-induced inflammation model using human umbilical vein endothelial cells (HUVECs), quercetin significantly suppressed the upregulation of Ob-Ra (leptin receptor) expression, ERK1/2 phosphorylation, NFкB, and TNF-α. Furthermore, in a neonatal rat cardiac fibroblast, quercetin inhibited TNF-α, IL-1β, and IL-6 secretion by inhibiting the activation of NFкB and Akt induced by lipopolysaccharide (LPS).
Luteolin
Luteolin or 3’, 4’, 5, 7-tetrahydroxyflavone is one of the most prevalent flavones widely found in fruits and vegetables such as carrots, cabbages, parsley, broccoli, celery, and apple skins.
In an in-vivo sodium fluoride-induced hypertensive model, administration of luteolin increased nitric oxide (NO) bioavailability, reversed prolongation of QT and QTc intervals, and reduced the expressions of kidney injury marker 1 (Kim-1), NFκB, and cardiac troponin I (CTnI), which eventually normalized the blood pressure. Previous study in neonatal rat cardiac myocytes exposed to LPS showed luteolin reduced the TNF-α levels in the medium, downregulated the TNF-α mRNA in myocytes, inhibited degradation of IκB-β and nuclear translocation of NFκB, as well as reduced NFκB DNA binding, proposing the therapeutic potential of luteolin the management of inflammation-related myocardial diseases.
Fisetin
Fisetin or 3, 3c,4c,7-tetrahydroxyflavone is a bioactive molecule found in fruits such as strawberry, apple, persimmon, and grape and vegetables such as onion and cucumber.
reported the protective effect of fisetin against isoproterol-induced myocardial injury by suppressing myocardial injury markers, creatine kinase-muscle/brain (CK-MB), lactate dehydrogenase (LDH), and inflammatory markers (TNF-α and IL-6) in the blood serum as well as normalization of histological and ultrastructure of the heart. In addition, fisetin regulated the balance between pro- or anti-oxidants and pro- or anti-apoptotics proteins in the myocardial tissue. These protective effects of fisetin are attributed to the downregulation of receptor for advanced glycation end products (RAGE) and NFκB.
Fisetin attenuated the development of diabetic cardiomyopathy by attenuating the expression of myocardial NFκB and the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in the heart of diabetic rats. These result in reduction of cardiac function markers such as CK-MB, LDH, and cTn as well as normalization heart morphology.
Apigenin
Apigenin, a flavone, is found widely available in fruits and vegetables, such as grapefruits, oranges, celeries, and onions.
In LPS-treated macrophages, apigenin has been shown to reduce toll-like receptor 4 (TLR-4), MyD88, and p-IκB-α expression levels via nuclear NFκB p65 signaling pathway. Similarly, in LPS-challenged apoE-/- mice, treatment with apigenin increased expression of ATP binding cassette A1 (ABCA1), which alleviated extra lipid accumulation, reduced miR-33, TLR-4, and NFκB p65 levels, lessened the macrophages and smooth muscle cell contents in the atherosclerotic region, and improved plasma lipid profile. These results suggested that apigenin attenuates atherogenesis by inhibition of nuclear NFκB p65 that up-regulates ABCA1-mediated cholesterol efflux.
Apigenin was also shown to improve cardiac dysfunction and fibrosis in diabetic cardiomyopathy. Apigenin blunted the activity of NFκB and downregulated the activity of caspase3 accompanying with decreasing oxidative stress marker, glutathione peroxidase (GSH-Px), malondialdehyde (MAD), and superoxide dismutase (SOD).
Isoliquiritigenin
Isoliquiritigenin is extracted from root of licorice and has been used traditionally for the treatment of inflammatory or pulmonary diseases. In HUVECS exposed to TNF-α, isoliquiritigenin blocked the involvement of NFкB at the transcriptional levels, and thus attenuated the downstream expression of VCAM-1, E-selectin, THP-1 monocyte adhesion, IкB-α, and PECAM-1, suggesting the protective effects of isoliquiritigenin through NFкB-dependent mechanisms. In angiotensin II induced hypertension model, isoliquiritigenin attenuated inflammation cytokines including IL-1β and TNF-α, excessive deposition of extracellular matrix, and oxidative stress-induced apoptosis via nuclear factor E2-related factor 2 (Nrf2) and NFκB pathways.
Rutin
Rutin is a flavonol that presents in buckwheat and citrus fruits. In a sodium fluoride-induced hypertensive rats, administration of rutin reduced blood pressure elevation by enhancing NO bioavailability via down-regulation of NFκB expression and up-regulation of Nrf2.
In carfilzomib-induced cardiotoxicity in rat, rutin protected against myocardial hypertrophy by upregulating IκB-α and downregulating NFκB expression, resulting in attenuation of β-myosin heavy chain, reduction in B-type natriuretic peptide mRNA expressions, and normalization of cardiac muscle fiber morphology.
In addition, rutin increased activities of Nrf, decreased activation of NFκB in human embryonic kidney reporter cell line, and preserved relaxation of fetal placental arteries derived from human chorionic plate.
In high mobility group box 1 (HMGBI)-induced inflammatory response in HUVECs, rutin attenuated NFκB and ERK1/2, which, in turn, reduced IL-6 and TNF-α levels. Up-regulation of VCAM-1, intercellular adhesion molecule-1 (ICAM-1), and E-selectin induced by HMGB1 were similarly inhibited by rutin, suggesting that the protective effect of rutin on vascular inflammation is by inhibiting the HMGB1 and NFκB pathways.
In LPS-induced inflammation in HUVECs, rutin reversed barrier disruption, expression of cell adhesion molecules, and adhesion and migration of monocytes in endothelial cells. The barrier protective effects of rutin were linked to a down-regulation of TNF-α, deactivation of NFκB, and reduced phosphorylation of IκB-α.
Chrysin
Chrysin (5,7-dihydroxyflavone) is a flavone, which is found in the blue passion flower, honey, and propolis. Chrysin prevented doxorubicin (DOX)-induced cardiomyopathy including disturbance of cardiac conduction, increased serum cardiac markers and histopathological alteration in heart of rat via downregulation of NFκB, mitogen-activated protein kinase (MAPK), suppression of AKT pathway and its upstream activator, vascular endothelial growth factor (VEGF).
In a rat model of monocrotaline-induced pulmonary arterial hypertension (PAH), chrysin reduced right ventricular systolic pressure and mean pulmonary artery pressure. In addition to suppression of right ventricular remodeling, chrysin abolished increased expression of collagen I, collagen III, and NFκB.
In isoprenaline-induced myocardial injury in rats, chrysin relieved hemodynamic and ventricular dysfunction as well as reduced ultrastructural myocardial damage via inhibition of NFκB, IκKβ expression, and TNF-α level as well as increased peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression.
In a rat model of myocardial infarction, fibrosis in the interstitial and perivascular regions and expression of collagen was reduced following chrysin treatment. This effect is associated with increased PPAR-γ expression and decreased NFκB expression via inhibition of IκKβ phosphorylation, leading to reduction of matrix metalloproteinase-2 (MMP-2), MMP-9 levels, and suppression of activator protein 1 (AP-1) level.
Genistein
Genistein under the subgroup of an isoflavone [4′,5,7-trihydroxyisoflavone,5,7-dihydroxy-3-(4-hydroxyphenyl)-4-H-1-benzopyran-4-one] is primarily found in soy-based foods, legumes, and red clover. In homocysteine-induced endothelial cell inflammatory injury, genistein prevented endothelial damage via blockade of activation of NFκB, expression of inflammatory cytokine and adhesion molecule, IL-6, and ICAM-1.
explored the effect of genistein on angiotensin II-induced vascular smooth muscle cell inflammation. Angiotensin II-induced expression of NFκB, C-reactive protein (CRP), MMP-9, phosphorylation of ERK1/2 and p-38, which lead to atherosclerotic inflammatory damage, were reversed following genistein treatment. Furthermore, genistein enhanced expression of PPAR-γ, suggesting cardiovascular protective effect by the isoflavone is through regulation of p38/ERK1/2-PPARγ-NFκB signaling pathway.
Silymarin
Silymarin is a flavonolignan extracted from the milk thistle. Silymarin augmented relaxation of pulmonary arteries isolated from a lung ischemia-reperfusion (I/R) injury model. Vascular protective effect of silymarin is due to inhibition of NFκB, thus suppressing the serum concentration of inflammatory cytokines and reducing protein expression of hypoxia inducible factor-1α (HIF-1α) and iNOS.
Silibinin, a major active constituent of silymarin, was able to reduce the abnormal size of cardiac myocytes and prevent hypertrophy by alleviating the production of epidermal growth factor receptor (EGFR). Silibilin exerted its anti-inflammatory effect by suppressing the activation of NFκB stimulated by angiotensin II in cardiac myocytes or in the aortic banding male mice. Furthermore, silibilin interfered with the phosphorylation and degradation of IκB-α and activation of IκKβ in vivo.
Kaempferol
Kaempferol (3,4′,5,7-tetrahydroxyflavone) is a flavonol that is present widely in fruits, vegetables, and herbs, including grapes, tomatoes, and tea. In cardiac fibroblasts stimulated with LPS, kaempferol decreased release of pro-inflammatory cytokines by inhibiting AKT phosphorylation and NFκB activation. In isoprenaline-induced cardiac damage, kaempferol improved the hemodynamic and left ventricular functions in male rats, which abated the increased serum concentration of CK-MB and LDH, preserved the morphology of myocardium, and reduced the levels of pro-inflammatory cytokines. Similarly, kaempferol prevented cardiac damage by inhibiting the protein expression of NFκB, p38, and JNK suggesting that cardioprotective and anti-inflammatory action of kaempferol was associated with NFκB signaling pathway.
Table 1 summarizes the effects and mechanisms of action of flavonoids in CVD.
Conclusion
The actions of flavonoids in mitigating inflammation by modulation of NFкB offer potential agents for the treatment of CVDs. However, several of these actions reported in vitro may yet to be fully recognized due to their low bioavailabilities following oral administration. Flavonoids have shown promising results in reducing atherosclerosis in several animal experimental models; however, conflicting results were reported in human clinical trials. The low bioavailability and clinical efficacy of flavonoids are attributed to their poor absorption, metabolism by the metabolizing enzymes in the intestine and liver, and structural modifications by the colonic bacteria remain as the major problems. Continuous investigation is required to enhance the bioavailability and efficacy of the flavonoids to tap the full potential of these natural agents.
Author Contributions
All authors contributed to the writing. KC, DM, and MM conceived, designed, and revised the manuscript.
Funding
This study was funded by Government Agency grant GA001-2017, MAHSA University and USIM research project code: PPPI/FPG/0118/051000/15618 Universiti Kebangsaan Malaysia and Universiti Putra Malaysia. The funding agencies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript, which are fully the responsibilities of the authors.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The reviewer ZJ declared a shared affiliation, with no collaboration, with one of the authors, XFL, to the handling editor at time of review
References 65
- 1.
Ai W. Zhang Y. Tang Q. Z. Yan L. Bian Z. Y. Liu C. (2010 ). Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. J. Cell. Biochem. 110, 1111–1122.
Not in our library10.1002/jcb.22623
- 2.
Alkhalidy H. Wang Y. Liu D. (2018 ). Dietary flavonoids in the prevention of t2d: an overview. Nutrients 10, 1–33.
Not in our library10.3390/nu10040438
- 3.
Althunibat O. Y. Al Hroob A. M. Abukhalil M. H. Germoush M. O. Bin-Jumah M. Mahmoud A. M. (2019 ). Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy. Life Sci. 221, 83–92.
Not in our library10.1016/j.lfs.2019.02.017
- 4.
Arai Y. Watanabe S. Kimira M. Shimoi K. Mochizuki R. Kinae N. (2000 ). Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 130, 2243–2250.
Not in our library10.1093/jn/130.9.2243
- 5.
Arikawa M. Kakinuma Y. Noguchi T. Todaka H. Sato T. (2016 ). Donepezil, an acetylcholinesterase inhibitor, attenuates LPS-induced inflammatory response in murine macrophage cell line RAW 264.7 through inhibition of nuclear factor kappa B translocation. Eur. J. Pharmacol. 789, 17–26.
Not in our library10.1016/j.ejphar.2016.06.053
- 6.
Arts I. C. Hollman P. C. (2005 ). Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81(1 Suppl), 317s–325s.
Not in our library10.1093/ajcn/81.1.317s
- 7.
- 8.
Barreca D. Gattuso G. Bellocco E. Calderaro A. Trombetta D. Smeriglio A. (2017 ). Flavanones: Citrus phytochemical with health-promoting properties. Biofactors 43, 495–506.
Not in our library10.1002/biof.1363
- 9.
Benjamin E. J. Blaha M. J. Chiuve S. E. Cushman M. Das S. R. Deo R. (2017 ). Heart disease and stroke statistics-2017 update: a report from the american heart association. Circulation 135, e146–e603.
Not in our library10.1161/cir.0000000000000485
- 10.
Brasier A. R. (2010 ). The nuclear factor-κB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 86, 211–218.
Not in our library10.1093/cvr/cvq076
- 11.
Chekalina N. Burmak Y. Petrov Y. Borisova Z. Manusha Y. Kazakov Y. (2018 ). Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease. Indian Heart J. 70, 593–597.
Not in our library10.1016/j.ihj.2018.04.006
- 12.
Da Silva Franco N. Lubaczeuski C. Guizoni D. M. Victorio J. A. Santos-Silva J. C. Brum P. C. (2017 ). Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice. Pharmacol. Res. 122, 35–45.
Not in our library10.1016/j.phrs.2017.05.018
- 13.
Daher M. T. Mougenot N. Rohr O. Bausero P. Liu P. Li Z. (2019 ). Role of the transcription factor Bcl11b in cardiac homeostasis and remodeling. Arch. Cardiovasc. Dis. Suppl. 11, 231.
Not in our library10.1016/j.acvdsp.2019.02.109
- 14.
Di Raimondo D. Tuttolomondo A. Butta C. Miceli S. Licata G. Pinto A. (2012 ). Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr. Pharm. Des. 18, 4385–4413.
Not in our library10.2174/138161212802481282
- 15.
Garg S. Malhotra R. K. Khan S. I. Sarkar S. Susrutha P. N. Singh V. (2019 ). Fisetin attenuates isoproterenol-induced cardiac ischemic injury in vivo by suppressing RAGE/NF-kappaB mediated oxidative stress, apoptosis and inflammation. Phytomedicine 56, 147–155.
Not in our library10.1016/j.phymed.2018.09.187
- 16.
Ghosh J. Das J. Manna P. Sil P. C. (2009 ). Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: Role of NF-κB, p38 and JNK MAPK pathway. Toxicol. Appl. Pharmacol. 240, 73–87.
Not in our library10.1016/j.taap.2009.07.008
- 17.
Han S. Wu H. Li W. Gao P. (2015 ). Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury. Mol. Cell. Biochem. 403, 43–49.
Not in our library10.1007/s11010-015-2335-0
- 18.
Haybar H. Rezaeeyan H. Shahjahani M. Shirzad R. Saki N. (2019 ). T-bet transcription factor in cardiovascular disease: attenuation or inflammation factor? J. Cell Physiol. 234, 7915–7922.
Not in our library10.1002/jcp.27935
- 19.
Hollman P. C. Katan M. B. (1998 ). Bioavailability and health effects of dietary flavonols in man. Arch. Toxicol. Suppl. 20, 237–248.
Not in our library10.1007/978-3-642-46856-8_21
- 20.
Huangjun L. Zheng Y. Wei D. Qizhu T. (2016 ). GW27-e0367 Apigenin attenuates the cardiac remodeling in experimental diabetic cardiomyopathy. J. Am. Coll. Cardiol. 68, 1–10. 27364043
Not in our library10.1016/j.jacc.2016.07.054
- 21.
Imam F. Al-Harbi N. O. Al-Harbia M. M. Korashy H. M. Ansari M. A. Sayed-Ahmed M. M. (2017 ). Rutin attenuates carfilzomib-induced cardiotoxicity through inhibition of NF-κB, hypertrophic gene expression and oxidative stress. Cardiovasc. Toxicol. 17, 58–66.
Not in our library10.1007/s12012-015-9356-5
- 22.
Indra M. R. Karyono S. Ratnawati R. Malik S. G. (2013 ). Quercetin suppresses inflammation by reducing ERK1/2 phosphorylation and NF kappa B activation in Leptin-induced Human Umbilical Vein Endothelial Cells (HUVECs). BMC Res. Notes 6, 275–275.
Not in our library10.1186/1756-0500-6-275
- 23.
Jin Y. Zhao X. Zhang H. Li Q. Lu G. Zhao X. (2016 ). Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injury. Exp. Therapeutic Med. 12, 1135–1140.
Not in our library10.3892/etm.2016.3370
- 24.
Khalil M. I. Sulaiman S. A. (2010 ). The potential role of honey and its polyphenols in preventing heart diseases: a review. Afr. J. Tradition. Complementary Alternative Med.: AJTCAM 7, 315–321.
Not in our library10.4314/ajtcam.v7i4.56693
- 25.
- 26.
Koeners M. P. Wesseling S. Sanchez M. Braam B. Joles J. A. (2016 ). Perinatal Inhibition of NF-KappaB has long-term antihypertensive and renoprotective effects in fawn-hooded hypertensive rats. Am. J. Hypertens. 29, 123–131.
Not in our library10.1093/ajh/hpv065
- 27.
- 28.
Kwon H. M. Choi Y. J. Choi J. S. Kang S. W. Bae J. Y. Kang I. J. (2007 ). Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-kappaB signal disruption. Exp. Biol. Med. (Maywood) 232, 235–245.
Not in our library10.3181/00379727-207-2320235
- 29.
Lee W. Ku S.-K. Bae J.-S. (2012 ). Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo. Food Chem. Toxicol. 50, 3048–3055.
Not in our library10.1016/j.fct.2012.06.013
- 30.
Li X. Guo B. Shen Y. Yang J. (2015 ). Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats. Yao Xue Xue Bao= Acta Pharma. Sin. 50, 1128–1134.
Not in our library10.1016/j.jash.2017.03.008
- 31.
- 32.
Lin X. Wu M. Liu B. Wang J. Guan G. Ma A. (2015 ). Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factorkappaB, monocyte chemoattractant protein1, activator protein1 and restoration of heat shock protein 72. Mol. Med. Rep. 12, 8193–8200.
Not in our library10.3892/mmr.2015.4432
- 33.
Lv L. Lv L. Zhang Y. Kong Q. (2011 ). Luteolin prevents LPS-induced TNF-alpha expression in cardiac myocytes through inhibiting NF-kappaB signaling pathway. Inflammation 34, 620–629.
Not in our library10.1007/s10753-010-9271-7
- 34.
Manach C. Scalbert A. Morand C. Remesy C. Jimenez L. (2004 ). Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727–747.
Not in our library10.1093/ajcn/79.5.727
- 35.
Mantawy E. M. Esmat A. El-Bakly W. M. Eldin R.a.S. El-Demerdash E. (2017 ). Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: plausible roles of p53, MAPK and AKT pathways. Sci. Rep. 7, 4795.
Not in our library10.1038/s41598-017-05005-9
- 36.
Marzocchella L. Fantini M. Benvenuto M. Masuelli L. Tresoldi I. Modesti A. (2011 ). Dietary flavonoids: molecular mechanisms of action as anti- inflammatory agents. Recent Pat. Inflamm. Allergy Drug Discov. 5, 200–220.
Not in our library10.2174/187221311797264937
- 37.
Osakabe N. (2013 ). Flavan 3-ols improve metabolic syndrome risk factors: evidence and mechanisms. J. Clin. Biochem. Nutr. 52, 186–192.
Not in our library10.3164/jcbn.12-130
- 38.
Oyagbemi A. A. Omobowale T. O. Ola-Davies O. E. Asenuga E. R. Ajibade T. O. Adejumobi O. A. (2018 a). Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications. BioFactors 44, 518–531.
Not in our library10.1002/biof.1449
- 39.
Oyagbemi A. A. Omobowale T. O. Ola-Davies O. E. Asenuga E. R. Ajibade T. O. Adejumobi O. A. (2018 b). Ameliorative effect of Rutin on sodium fluoride-induced hypertension through modulation of Kim-1/NF-κB/Nrf2 signaling pathway in rats. Environ. Toxicol. 33, 1284–1297.
Not in our library10.1002/tox.22636
- 40.
- 41.
Peng F. Du Q. Peng C. Wang N. Tang H. Xie X. (2015 ). A review: the pharmacology of isoliquiritigenin. Phytother. Res. 29, 969–977.
Not in our library10.1002/ptr.5348
- 42.
Pollastri S. Tattini M. (2011 ). Flavonols: old compounds for old roles. Ann. Bot. 108, 1225–1233.
Not in our library10.1093/aob/mcr234
- 43.
Quintana-Villamandos B. Goukassian D. A. Sasi S. P. Delgado-Baeza E. (2018 ). Short-term treatment with esmolol reverses left ventricular hypertrophy in adult spontaneously hypertensive rats via inhibition of Akt/NF-κB and NFATc4. BioMed. Res. Int. 2018, 9.
Not in our library10.1155/2018/2691014
- 44.
Rani N. Bharti S. Bhatia J. Nag T. Ray R. Arya D. S. (2016 ). Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chemico-Biol. Interact. 250, 59–67.
Not in our library10.1016/j.cbi.2016.03.015
- 45.
Ren K. Jiang T. Zhou H. F. Liang Y. Zhao G. J. (2018 ). Apigenin retards atherogenesis by promoting abca1-mediated cholesterol efflux and suppressing inflammation. Cell Physiol. Biochem. 47, 2170–2184.
Not in our library10.1159/000491528
- 46.
Ruparelia N. Chai J. T. Fisher E. A. Choudhury R. P. (2017 ). Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat. Rev. Cardiol. 14, 133–144.
Not in our library10.1038/nrcardio.2016.185
- 47.
Shih V. F.-S. Tsui R. Caldwell A. Hoffmann A. (2011 ). A single NFκB system for both canonical and non-canonical signaling. Cell Res. 21, 86–102.
Not in our library10.1038/cr.2010.161
- 48.
Smale S. T. Natoli G. (2014 ). Transcriptional control of inflammatory responses. Cold Spring Harb. Perspect. Biol. 6, a016261.
Not in our library10.1101/cshperspect.a016261
- 49.
Sthijns M. M. Schiffers P. M. Janssen G. M. Lemmens K. J. Ides B. Vangrieken P. (2017 ). Rutin protects against H2O2-triggered impaired relaxation of placental arterioles and induces Nrf2-mediated adaptation in human umbilical vein endothelial cells exposed to oxidative stress. Biochim. Biophys. Acta (BBA)-General Subjects 1861, 1177–1189.
Not in our library10.1016/j.bbagen.2017.03.004
- 50.
Suchal K. Malik S. Gamad N. Malhotra R. K. Goyal S. N. Bhatia J. (2016 a). Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats. Phytomedicine 23, 1401–1408.
Not in our library10.1016/j.phymed.2016.07.015
- 51.
Suchal K. Malik S. Gamad N. Malhotra R. K. Goyal S. N. Chaudhary U. (2016 b). Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury. Oxidative Med. Cell. Longevity 2016, 1–1.
Not in our library10.1155/2016/7580731
- 52.
Sun S.-C. (2017 ). The non-canonical NF-κB pathway in immunity and inflammation. Nat. reviews. Immunol. 17, 545–558.
Not in our library10.1038/nri.2017.52
- 53.
Tang X.-l. Liu J.-x. Dong W. Li P. Li L. Hou J.-c. (2015 ). Protective effect of kaempferol on LPS plus ATP-induced inflammatory response in cardiac fibroblasts. Inflammation 38 (1), 94–101.
Not in our library10.1007/s10753-014-0011-2
- 54.
Tang X.-L. Liu J.-X. Dong W. Li P. Li L. Zheng Y.-Q. (2014 ). Intervention effect of quercetin on inflammatory secretion of cardiac fibroblasts.
Not in our library
- 55.
- 56.
Van Der Heiden K. Cuhlmann S. Luong Le A. Zakkar M. Evans P. C. (2010 ). Role of nuclear factor kappaB in cardiovascular health and disease. Clin. Sci. (Lond) 118, 593–605.
Not in our library10.1042/cs20090557
- 57.
Wang X. Chen Q. Pu H. Wei Q. Duan M. Zhang C. (2016 ). Adiponectin improves NF-kappaB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice. Lipids Health Dis. 15, 33.
Not in our library10.1186/s12944-016-0202-y
- 58.
Weng C. J. Yen G. C. (2012 ). Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev. 31, 323–351.
Not in our library10.1007/s10555-012-9347-y
- 59.
Xiong D. Hu W. Ye S.-T. Tan Y.-S. (2018 ). Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways. Biochem. Biophysical Res. Commun. 506, 161–168.
Not in our library10.1016/j.bbrc.2018.09.013
- 60.
Xu L. Liu J.-T. Li K. Wang S.-Y. Xu S. (2019 ). Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells. Life Sci. 216, 140–146.
Not in our library10.1016/j.lfs.2018.11.036
- 61.
Yang M. Xiong J. Zou Q. Wang D.-D. Huang C.-X. (2018 ). Chrysin attenuates interstitial fibrosis and improves cardiac function in a rat model of acute myocardial infarction. J. Mol. histology 49, 555–565.
Not in our library10.1007/s10735-018-9793-0
- 62.
Yoo H. Ku S.-K. Baek Y.-D. Bae J.-S. (2014 ). Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo. Inflammation Res. 63, 197–206.
Not in our library10.1007/s00011-013-0689-x
- 63.
Zeinali M. Rezaee S. A. Hosseinzadeh H. (2017 ). An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances. Biomed Pharmacother 92, 998–1009.
Not in our library10.1016/j.biopha.2017.06.003
- 64.
Zhao H. Shen R. Dong X. Shen Y. (2017 ). Murine double minute-2 inhibition attenuates cardiac dysfunction and fibrosis by modulating nf-kappab pathway after experimental myocardial infarction. Inflammation 40, 232–239.
Not in our library10.1007/s10753-016-0473-5
- 65.
Zordoky B. N. M. Robertson I. M. Dyck J. R. B. (2015 ). Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852 (6), 1155–1177.
Not in our library10.1016/j.bbadis.2014.10.016
Cited by papers we hold 7
- Plant Polyphenols and Their Potential Benefits on Cardiovascular Health: A Review · 2023No notice
- Inhibitory potential of rutin on lipopolysaccharide-induced toxicity and inflammatory response of raw U937 cells and macrophages · 2022Not checked
- Integrating experimental model, LC-MS/MS chemical analysis, and systems biology approach to investigate the possible antidiabetic effect and mechanisms of Matricaria aurea (Golden Chamomile) in type 2 diabetes mellitus · 2022Not checked
- Genistein: A Review on its Anti-Inflammatory Properties · 2022No notice
- Flavonoids as Potential Anti-Inflammatory Molecules: A Review · 2022No notice
- Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns · 2021No notice
- Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and Disease · 2018Not checked
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.